The Importance of Adherence for HIV Prevention
Author Information
Author(s): Helen A. Weiss, Judith N. Wasserheit, Ruanne V. Barnabas, Richard J. Hayes, Laith J. Abu-Raddad
Primary Institution: London School of Hygiene & Tropical Medicine
Hypothesis
How does varying adherence levels impact the efficacy of HIV prevention strategies in randomized controlled trials?
Conclusion
Poor adherence during a trial can significantly reduce the ability to detect an effect, highlighting the need for improved adherence methods.
Supporting Evidence
- Only four out of 31 completed randomized controlled trials of HIV prevention strategies have shown significant efficacy.
- At 100% adherence, the measured efficacy is a reasonable approximation of true biological efficacy.
- At 60% adherence, the measured efficacy can be less than half of the true biological efficacy.
Takeaway
If people don't stick to their HIV prevention methods, those methods might not work as well as they could. It's really important to help people stay on track.
Methodology
The study used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy in randomized controlled trials.
Limitations
The study relies on simplifying assumptions about sexual behavior and transmission probabilities, which may not reflect real-world complexities.
Statistical Information
Confidence Interval
95% CI 43%–69%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website